Top Markets
#1 GEKKO GEKKO +51.79%
#2 ADO Protocol ADO Protocol +38.56%
#3 Helium Helium +33.04%
#4 Pons Pons +32.20%
#5 TENDIES TENDIES +25.20%
#6 龙虾 (Lobster) 龙虾 (Lobster) +20.40%
#7 Giggle Fund Giggle Fund +20.30%
#8 CZ'S Dog CZ'S Dog +19.95%
#9 o1.exchange o1.exchange +18.05%
#10 Main Street Yield Main Street Yield +17.48%
Coin of the day
GEKKO GEKKO
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Harrow Health, Inc. 8.625% Senior Notes due 2026 Harrow Health, Inc. 8.625% Senior Notes due 2026

Harrow Health, Inc. 8.625% Senior Notes due 2026

HROWL
Pozycja w akcjach #8091
Harrow, Inc. is a pharmaceutical company that specializes in the development,... Harrow, Inc. is a pharmaceutical company that specializes in the development, production, and distribution of innovative medications. Its business activities are primarily divided into two segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding division notably encompasses the operations of the ImprimisRx business. Co-founded by Mark L. Baum and Robert J. Kammer in January 2006, the firm maintains its corporate headquarters in Nashville, Tennessee.
Cena akcji
$25.61
Ostatnia synchronizacja: 2025-10-10
Kapitalizacja rynkowa
$1.37B
Zmiana (1 dzień)
0.20%
Zmiana (1 rok)
1.55%
Kraj
US
Handel Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)

Kategoria

Healthcare
Zyski dla Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych Harrow Health, Inc. 8.625% Senior Notes due 2026, obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Harrow Health, Inc. 8.625% Senior Notes due 2026 od 2026 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
Za mało danych dla podanych dat.
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
$992.42M -
HK
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT